Remicade Funding
- Date:
- 2000
- Reference:
- SA/KET/A/5/10
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Draft application to New Drugs Panel, Hammersmith Hospitals Anti-TNFa for treatment of rheumatoid arthritis; proposal for funding anti-TNF therapies for severe resistant rheumatoid arthritis; business case for NHS funding for Remicade (infliximab); The health economics of Remicade in Rheumatoid Arthritis value dossier. It is unclear whether the Kennedy Institute and Ravinder Maini were involved of all of these draft papers.
Publication/Creation
2000
Physical description
1 file
Terms of use
This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.
Where to find it
Location Status Access Closed storesBy appointment Manual request